A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom
31 August 2020 (08:30 - 08:30)
Organised by:
About the speaker
Amgen (Europe) GmbH, Rotkreuz (Switzerland)
4 More presentations in this session
Professor H. Seggewiss (Wurzburg, DE)
Mr A. Sigal (Buenos Aires, AR)
Doctor A. Ragab (Rotterdam, NL)
Access the full session
The Event
ESC Congress 2020
31 August 2020
08:30 CET
You may be interested in
Congress Session
